As of the latest SEC filings, GENSCRIPT BIOTECH CORP /HKD/ (GNNSF) is held by 3 institutional funds. The largest fund shareholder is Nuveen Emerging Markets Equity Index Fund (TEQKX), holding an estimated $1,627,264.48 in market value, representing 0.02% of its portfolio.
Funds holding GENSCRIPT BIOTECH CORP /HKD/ (GNNSF)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- GNNSF
- CIK:
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
TEQKX
Nuveen Emerging Markets Equity Index Fund
|
MF | TIAA / Nuveen | 0.02% | $1,627,264.48 | 914,000 | Apr 30, 2026 | Jun 24, 2026 |
|
NOEMX
Emerging Markets Equity Index Fund
|
MF | Independent / Boutique | 0.02% | $425,981.29 | 304,000 | Mar 31, 2026 | May 28, 2026 |
|
TEMUX
Emerging Markets Equity Fund
|
MF | Morgan Stanley | 0.01% | $73,405.23 | 48,000 | Feb 28, 2026 | Apr 27, 2026 |
Advertisement (320x50)